These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 124241)

  • 1. Pancreatic islet-cell toxicity.
    Fischer LJ; Rickert DE
    CRC Crit Rev Toxicol; 1975 Jan; 3(2):231-63. PubMed ID: 124241
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of superoxide dismutase, catalase, chelating agents, and free radical scavengers on the toxicity of alloxan to isolated pancreatic islets in vitro.
    Jörns A; Tiedge M; Lenzen S; Munday R
    Free Radic Biol Med; 1999 May; 26(9-10):1300-4. PubMed ID: 10381203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions of diabetogenic compounds: cyproheptadine and alloxan.
    Chatterjee AK; Varayotha V; Fischer LJ
    Fundam Appl Toxicol; 1991 Jan; 16(1):188-97. PubMed ID: 2019344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitivity of BB rat beta cells as determined by dose-responses to the cytotoxic effects of streptozotocin and alloxan.
    Yale JF; Grose M; Videtic GM; Marliss EB
    Diabetes Res; 1986 Mar; 3(3):161-7. PubMed ID: 2940045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemically induced (streptozotocin-alloxan) diabetes mellitus in the dog. Biochemical and ultrastructural studies.
    Black HE; Rosenblum IY; Capen CC
    Am J Pathol; 1980 Feb; 98(2):295-310. PubMed ID: 6444498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin 1 beta-mediated destruction of pancreatic beta-cells in vitro. A model of beta-cell destruction in insulin-dependent diabetes mellitus?
    Helqvist S
    Dan Med Bull; 1994 Apr; 41(2):151-66. PubMed ID: 8039431
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of streptozotocin and alloxan-induced diabetes in the rat, including volumetric quantitation of the pancreatic islets.
    Hoftiezer V; Carpenter AM
    Diabetologia; 1973 Jun; 9(3):178-84. PubMed ID: 4268550
    [No Abstract]   [Full Text] [Related]  

  • 8. Islet cell membrane alteration by diabetogenic drugs.
    Orci L; Amherdt M; Malaisse-Lagae F; Ravazzola M; Malaisse WJ; Perrelet A; Renold AE
    Lab Invest; 1976 May; 34(5):451-4. PubMed ID: 131879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of poly(ADP-ribose) synthetase in the development of insulin-dependent diabetes and islet B-cell regeneration.
    Okamoto H
    Biomed Biochim Acta; 1985; 44(1):15-20. PubMed ID: 2986610
    [No Abstract]   [Full Text] [Related]  

  • 10. DNA strand breaks in pancreatic islets by in vivo administration of alloxan or streptozotocin.
    Yamamoto H; Uchigata Y; Okamoto H
    Biochem Biophys Res Commun; 1981 Dec; 103(3):1014-20. PubMed ID: 6460502
    [No Abstract]   [Full Text] [Related]  

  • 11. Streptozotocin-diabetes in the Chinese hamster. Long-term effects on the light microscopic structure of the pancreatic islet tissue, liver and kidney.
    Wilander E
    Acta Pathol Microbiol Scand A; 1974 Nov; 82(6):767-76. PubMed ID: 4280870
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of high or low dose of streptozocin on pancreatic islets in C57BL/6 and C.B17-SCID mice.
    Lu WT; Juang JH; Hsu BR; Huang HS
    Transplant Proc; 1998 Mar; 30(2):609-10. PubMed ID: 9532197
    [No Abstract]   [Full Text] [Related]  

  • 13. An in vitro, sex dependents, and direct cytotoxic effect of streptozotocin on pancreatic islet cells.
    Kromann H; Christy M; Lernmark A; Nerup J
    Horm Metab Res; 1981 Feb; 13(2):120-1. PubMed ID: 6453073
    [No Abstract]   [Full Text] [Related]  

  • 14. Species dependent pancreatic islet toxicity produced by cyproheptadine: alterations in beta cell structure and function.
    Wold JS; Longnecker DS; Fischer LJ
    Toxicol Appl Pharmacol; 1971 Jun; 19(2):188-201. PubMed ID: 4936848
    [No Abstract]   [Full Text] [Related]  

  • 15. Induction of diabetes in animal models for pancreatic islet research.
    Jindal RM
    Pancreas; 1996 Mar; 12(2):209-11. PubMed ID: 8720673
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of Acute Gene Expression Profiles of Islet Cells Obtained via Laser Capture Microdissection between Alloxan- and Streptozotocin-treated Rats.
    Kato Y; Masago Y; Kondo C; Yogo E; Torii M; Hishikawa A; Izawa T; Kuwamura M; Yamate J
    Toxicol Pathol; 2018 Aug; 46(6):660-670. PubMed ID: 29929439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of cyproheptadine on glucose tolerance, serum insulin and structure of pancreatic islets in rats.
    Chakrabarty AS; Pourany A; Ananthanarayanan PH; Subramanian N; Rathinaswamy P; Chakrabarty K
    Indian J Exp Biol; 1990 Aug; 28(8):721-3. PubMed ID: 2253963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism underlying resistance of human pancreatic beta cells against toxicity of streptozotocin and alloxan.
    Elsner M; Tiedge M; Lenzen S
    Diabetologia; 2003 Dec; 46(12):1713-4. PubMed ID: 14614558
    [No Abstract]   [Full Text] [Related]  

  • 19. Streptozocin- and alloxan-induced H2O2 generation and DNA fragmentation in pancreatic islets. H2O2 as mediator for DNA fragmentation.
    Takasu N; Komiya I; Asawa T; Nagasawa Y; Yamada T
    Diabetes; 1991 Sep; 40(9):1141-5. PubMed ID: 1834504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA strand breaks and poly(ADP-ribose) synthetase activation in pancreatic islets--a new aspect to development of insulin-dependent diabetes and pancreatic B-cell tumors.
    Okamoto H; Yamamoto H
    Princess Takamatsu Symp; 1983; 13():297-308. PubMed ID: 6317640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.